Supplemental Figure 5 from MCL-1 is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor
crossref（2023）
摘要
Supplemental Figure 5: Flavopiridol synergizes with navitoclax in breast cancer cell lines in vitro.
更多查看译文
关键词
Cancer Cell Metabolism
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要